Winton Group LTD Vertex Pharmaceuticals Inc Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Winton Group LTD holds 7,508 shares of VRTX stock, worth $3.3 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

7,508

Holding current value

$3.3 Million

% of portfolio

0.27%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $3.45 Million - $3.8 Million	7,508 New	7,508 $3.49 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $2.38 Million - $2.85 Million	6,944 Added 440.33%	8,521 $3.47 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $110,584 - $118,524	327 Added 26.16%	1,577 $548,000
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $3.19 Million - $3.58 Million	-10,161 Reduced 89.05%	1,250 $439,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $84,402 - $96,283	298 Added 2.68%	11,411 $3.6 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.59 Million - $1.79 Million	5,574 Added 100.63%	11,113 $3.21 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $3.45 Million - $3.85 Million	-12,597 Reduced 69.46%	5,539 $1.6 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $1.27 Million - $1.58 Million	-5,414 Reduced 22.99%	18,136 $5.11 Million
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $1.72 Million - $2.02 Million	7,753 Added 49.08%	23,550 $6.15 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $2.29 Million - $2.9 Million	12,962 Added 457.21%	15,797 $3.47 Million
Q3 2021 Oct 28, 2021	BUY	$181.39 - $202.99 $54,779 - $61,302	302 Added 11.92%	2,835 $514,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $87,745 - $103,474	468 Added 22.66%	2,533 $511,000
Q1 2021 Jul 21, 2021	BUY	$207.02 - $241.31 $18,424 - $21,476	89 Added 4.5%	2,065 $444,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $519,595 - $692,985	-2,510 Reduced 55.95%	1,976 $467,000
Q3 2020 Oct 30, 2020	SELL	$255.65 - $303.1 $3.07 Million - $3.64 Million	-12,004 Reduced 72.8%	4,486 $1.22 Million
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $3.16 Million - $4.15 Million	14,027 Added 569.51%	16,490 $4.79 Million
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $492,033 - $610,356	2,463 New	2,463 $586,000
Q2 2019 Jul 08, 2019	SELL	$164.61 - $190.37 $281,153 - $325,151	-1,708 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $47,154 - $56,073	-288 Reduced 14.43%	1,708 $314,000
Q4 2018 Feb 05, 2019	BUY	$151.91 - $192.21 $303,212 - $383,651	1,996 New	1,996 $331,000
Q2 2018 Aug 20, 2018	SELL	$145.72 - $169.96 $214,791 - $250,521	-1,474 Closed	0 $0
Q1 2018 May 21, 2018	SELL	$151.6 - $177.13 $29,713 - $34,717	-196 Reduced 11.74%	1,474 $0
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $7.55 Million - $8.55 Million	-54,967 Reduced 97.05%	1,670 $250,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $7.8 Million - $8.55 Million	52,675 Added 1329.51%	56,637 $8.61 Million
Q2 2017 Aug 17, 2017	BUY	N/A	3,962	3,962 $511,000

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

220M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account